Direct detection of early-stage cancers using circulating tumor DNAJillian Phallen, Victor E. Velculescu, Derek Murphy et al.|Science Translational Medicine|2017Cited by 1.1k
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer GroupMarinde J. G. Bond, Johanneke H.M.J.V. Vestjens, Karen Bolhuis et al.|The Lancet Oncology|2023Cited by 168
Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validationJ Michiel Zeeuw, Geert Kazemier, Nina J. Wesdorp et al.|European Journal of Cancer|2024Cited by 17
Development and external evaluation of a self-learning auto-segmentation model for Colorectal Cancer Liver Metastases Assessment (COALA)Jacqueline I. Bereska, Marco Del Chiaro, Michiel Zeeuw et al.|Insights into Imaging|2024Cited by 7
Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastasesNerma Crnovrsanin, Remond J.A. Fijneman, Michiel Zeeuw et al.|EBioMedicine|2025Cited by 4